Why the underestimated economic burden of rare diseases could be costing the U.S. trillions of dollars

Rare diseases have gained more attention in recent years, perhaps in part due to the high price tags often associated with approved therapies. But the cost of rare disease drugs is dwarfed by the cost of not having them. Our recent study shows that a lack of treatment for a rare disease is…#orphandrugtaxcredit #fda #petermarks #arc #learningandeducation #cder #nih #als #giacomochiesi #chiesigroup

Source: Reuters: Health - May 25, 2023 Category: Consumer Health News Source Type: news